A new study from researchers at the University of Illinois at Chicago, the University of Chicago Medicine and Johns Hopkins Bloomberg School of Public Health shows that since 2003, the use of alternative medicines, such as herbal products and nutraceuticals, among children has doubled.
A new study shows as many as one in 20 children were still receiving codeine to treat pain after tonsil and adenoid surgery, two years after federal regulators warned doctors that prescribing the opioid to kids after the routine surgeries could be fatal. The research from the University of Chicago Medicine, the University of Michigan and Harvard University was published in the journal Pediatrics.
Investigators from the University of Chicago Medicine will play a central role in a five-year, $14.8 million effort by the National Institutes of Health, contingent upon available funding, to improve the understanding of inherited diseases. The project, known as the Gabriella Miller Kids First pediatric data resource center, will be a multi-centered effort led by investigators at the Center for Data Driven Discovery in Biomedicine at the Children's Hospital of Philadelphia (CHOP). Two crucial components of the Kids First project, however, are the teams led by Robert L. Grossman, PhD, and Sam Volchenboum, MD, PhD, at the University of Chicago. Grossman and Volchenboum will play a central role in the technical underpinnings of the large-scale processing and sharing of genomic and clinical data for this important initiative.